Please login to the form below

Not currently logged in


This page shows the latest Influencer news and features for those working in and with pharma, biotech and healthcare.

Latest news

  • Don't hesitate, vaccinate! Don't hesitate, vaccinate!

    It might be to share some of your company’s information; it might be a public health or patient charity website; it might be a local or celebrity influencer commenting on

  • Q&A: Kate Callan Q&A: Kate Callan

    Working on that programme ultimately led me to shift focus to building our social media and influencer practice at our agency.

  • Evolving at home Evolving at home

    Pfeffer, and many other authorities, see these behaviour traits as characteristic of people who are good influencers. ... And I hope I can assume that my readers understand the value of being a good influencer.

  • 20/20 vision 20/20 vision

    Fake news. Every day, more sources of information become available and with social influencers on the increase, fake news and ‘bad science’ will continue to infiltrate our lives.

  • W2O acquires advertising and medical education agency 21GRAMS W2O acquires advertising and medical education agency 21GRAMS

    The acquisition strengthens W2O’s position in medical and scientific communications, and will extend the group’s engagement with healthcare influencers.The addition of 21GRAMS to the group’s roster also

More from news
Approximately 2 fully matching, plus 113 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 2 fully matching, plus 79 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 5 fully matching, plus 83 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company

Iguazu Ltd is a digital healthcare agency, delivering tactical and innovative solutions. WHAT WE DO We are Closed Loop Marketing...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Securing a future for telehealth with immersive market research insights...